SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Aug 15, 2025, 3:59 PM
2.21
0.91%
After-hours: Aug 15, 2025, 07:52 PM EDT
SAB Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | -410 | 263.14K | 944.58K | 305.01K | 1.27M | 85.52K | n/a | 2.16M | 3.59M | 6.35M | 11.8M | 60.88M | n/a | n/a | n/a |
Cost of Revenue | 822K | 778.3K | -1.68M | 1M | 1.02M | 1.99M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | n/a | n/a | 60.28M | n/a | n/a | n/a |
Gross Profit | -822K | -778.3K | -671K | -1M | -759K | -1.04M | -639K | 281.92K | -807K | n/a | 1.24M | 2.68M | 6.35M | 11.8M | 592.4K | -336K | -257K | n/a |
Operating Income | -9.73M | -10.77M | -10.01M | -11.31M | -10.2M | -11.39M | -18.87M | -5.32M | -6.48M | -7.4M | -7.86M | -7.81M | -6.54M | -6.71M | -12.69M | -336K | -2.87M | 813.92K |
Interest Income | 13.56K | 62.5K | 136.37K | 277.17K | 374.56K | 497.89K | 484.05K | 14.36K | 28.57K | 57.99K | 29.93K | 17.39K | 15.82K | 7.93K | 14.87K | 3.77K | 2.9K | 2.42K |
Pretax Income | -10.11M | -5.2M | -11.39M | -10.35M | -7.33M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.85M | -7.08M | -4.87M | 1.08M | -17.59M | -331K | -2.94M | 1.41M |
Net Income | -10.11M | -5.2M | -11.39M | -10.35M | -7.33M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.88M | -7.08M | -4.78M | 985.86K | -17.59M | -4.06M | -2.94M | 1.41M |
Selling & General & Admin | 2.74M | 3.12M | 2.67M | 3.48M | 2.64M | 2.23M | 14.88M | 2.57M | 2.9M | 3.45M | 2.84M | 4.04M | 4.31M | 5.19M | 17.09M | 3.6M | 2.4M | 3.33M |
Research & Development | 7M | 7.66M | 7.63M | 7.83M | 6.8M | 8.12M | 4.3M | 4.02M | 3.66M | 4.54M | 7.14M | 7.35M | 8.58M | 13.32M | 25.72M | 15.07M | 18.68M | 12.78M |
Other Expenses | n/a | n/a | -962K | -1M | 363.00 | -81 | -943.62K | -986.16K | -85.52K | -581K | -2.16M | -3.59M | -6.35M | -11.8M | -61.58M | -14.68M | -18.21M | -16.93M |
Operating Expenses | 9.73M | 10.77M | 9.34M | 10.31M | 9.44M | 10.35M | 18.23M | 5.6M | 5.67M | 7.4M | 7.86M | 7.81M | 6.54M | 6.71M | 12.69M | 335.55K | 2.87M | -814K |
Interest Expense | 64.34K | 69.56K | 70.88K | 78.04K | 93.12K | 76.37K | 77.88K | 69.7K | 75.32K | 92.39K | 87.7K | 70.63K | 71.24K | 72.02K | 294.46K | 78.56K | 74.43K | 75.19K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.73M | 10.77M | 11.45M | 11.31M | 10.46M | 12.34M | 19.18M | 6.59M | 6.48M | 7.4M | 10.02M | 11.4M | 6.54M | 18.51M | 97.36M | -336K | 2.87M | -814K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.63K | n/a | -92.28K | 92.28K | n/a | -4.72K | n/a | n/a |
Shares Outstanding (Basic) | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.31M | 4.35M | 4.35M | 4.35M | 4.35M |
Shares Outstanding (Diluted) | 9.29M | 9.29M | 9.26M | 9.26M | 9.26M | 9.24M | 5.93M | 5.24M | 5.04M | 5.04M | 5.04M | 4.3M | 4.3M | 4.58M | 4.35M | 4.35M | 4.35M | 4.35M |
EPS (Basic) | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.86 | -0.97 | -1.36 | -1.46 | -1.56 | -1.6 | -1.11 | 0.23 | -4.11 | -0.07 | -0.68 | 0.32 |
EPS (Diluted) | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.86 | -0.97 | -1.36 | -1.46 | -1.56 | -1.6 | -1.11 | 0.22 | -4.11 | -0.07 | -0.68 | 0.32 |
EBITDA | -9.73M | -4.35M | -10.54M | -9.3M | -6.19M | -2.96M | -21.83M | -4.05M | -5.91M | -6.34M | -6.84M | -6.1M | -4.02M | 1.83M | -16.15M | -3.57M | -2.57M | 1.76M |
EBIT | -10.05M | -5.13M | -11.32M | -10.27M | -7.24M | -4.95M | -22.78M | -5.03M | -6.81M | -7.26M | -7.76M | -7M | -4.8M | 1.15M | -16.15M | -331K | -2.87M | 1.49M |
Depreciation & Amortization | 822K | 778.3K | 785.71K | 966.86K | 1.06M | 1.99M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | 781K | 677.44K | -576K | 415.04K | 300.15K | 277.22K |